Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Wanna-Udom S, Luesiripong C, Sakunrangsit N, Metheepakornchai P, Intharamonthian S, Svasti S, et al. High phosphate intake induces bone loss in nephrectomized thalassemic mice. PLoS One. 2022;17(5):e0268732.

Boyraz B, James K, Hornick JL, Roberts DJ. Placental pathology from COVID-19-recovered (nonacute) patients. Hum Pathol. 2022;125:18-22.

Wakely PE, Siddiqui MT. Fine-needle aspiration cytopathology of soft tissue myoepithelioma: an analysis of seven cases. J Am Soc Cytopathol. 2022;11(1):31-39.

Velu P, Cong L, Rand S, Qiu Y, Zhang Z, Zhang J, et al. Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays. Diagn Microbiol Infect Dis. 2022;104(4):115789.

Marron TU, Fiel MI, Hamon P, Fiaschi N, Kim E, Ward SC, et al. Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial. Lancet Gastroenterol Hepatol. 2022;7(3):219-229.

Boyraz B, Watkins JC, Soubeyran I, Bonhomme B, Croce S, Oliva E, et al. Cystic Granulosa Cell Tumors of the Ovary: An Analysis of 80 Cases of an Often Diagnostically Challenging Entity. Arch Pathol Lab Med. 2022;146(12):1450-1459.

Young A, Bu W, Jiang W, Ku A, Kapali J, Dhamne S, et al. Targeting the Pro-survival Protein BCL-2 to Prevent Breast Cancer. Cancer Prev Res (Phila). 2022;15(1):3-10.

Solomon JP, Yang S-, Choudhury NJ, Ptashkin RN, Eslamdoost N, Falcon CJ, et al. Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 Tumors. Clin Cancer Res. 2022;28(21):4649-4659.

Smithgall MC, Murphy EA, Rand S, Sukhu A, Singh S, Schatz-Siemers N, et al. Placental pathology, neonatal birth weight, and Apgar score in acute and distant SARS-CoV-2 infection. J Clin Transl Res. 2022;8(5):351-359.

Mossanen M, Nassar AH, Stokes SM, Martinez-Chanza N, Kumar V, Nuzzo PV, et al. Incidence of Germline Variants in Familial Bladder Cancer and Among Patients With Cancer Predisposition Syndromes. Clin Genitourin Cancer. 2022;20(6):568-574.